Respiratory System
Asmatropim
-
-
Asmatropim:
(250 mcg/1 ml) , (500 mcg/2 ml)
lpratropium Bromide
Name of the medicinal product
Asmatropim 250 UDVs, I ml Asmatropim 500 UDVs, 2 ml
Qualitative and quantitative composition
Each single dose unit contains 0.025 % w/v ipratropium bromide (250 micrograms in I ml and 500
micrograms in 2 ml).
Pharmaceutical form
Nebulizer solution in unit dose vial.
Therapeutic Indications:
ASMATROPIM UDVs are indicated for treatment of reversible
bronchospasm associated with chronic obstructive pulmonary disease (COPD)
ASMATROPIM UDVs are indicated when concomitantly with
inhaled beta2-ragonists for treatment of reversible airways obstruction as in acute and chronic
asthma